Population-based differences in frequency of the transcobalamin II Pro259Arg polymorphism

Clinical Biochemistry

Volumn 37, Issue 2, 2004, Pages 128-133

  Bowen, Raffick A R ^a   Wong, Betty Y L ^b   Cole, David E C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cobalamin; Ethnic; Homocysteine; Methylmalonic acid; Mutagenically separated PCR; Polymorphism; Transcobalamin II

Indexed keywords

CYANOCOBALAMIN; TRANSCOBALAMIN II;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CAUCASIAN; CYANOCOBALAMIN DEFICIENCY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; VITAMIN METABOLISM;

EID: 0346023028     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.09.001     Document Type: Article

References (42)

1. 12 deficiency. 1999;1-81 Royal Society of Medicine Press, London.
2. Carmel R. Cobalamin, the stomach, ageing. Am. J. Clin. Nutr. 66:1997;750-759.
3. Stabler S.P., Sampson D.A., Wang L.P.et al. Elevation of serum cystathionine and total homocysteine in pyridoxine-, folate-, and cobalamin-deficient rats. J. Nutr. Biochem. 8:1997;279-289.
4. 12 deficiency in the elderly. Nutr. Health. 12:1998;215-226.
5. Ho C., Kauwell G.P., Bailey L.B. Practitioners' guide to meeting the vitamin B-12 recommended dietary allowance for people aged 51 years and older. J. Am. Diet Assoc. 99:1999;725-727.
6. 12 deficiency. Postgrad. Med. 110:2001;99-105.
7. Stabler S.P., Marcell P.D., Podell E.R.et al. Assay of MMA in the serum of patients with cobalamin deficiency using capillary gas chromatography/mass spectrometry. J. Clin. Invest. 77:1986;1606-1612.
8. Stabler S.P., Marcell P.D., Podell E.R., Allen R.H., Savage G., Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J. Clin. Invest. 81:1988;466-474.
9. 12 deficiency is the primary cause of megaloblastic anaemia in Zimbabwe. Br. J. Haematol. 86:1994;844-850.
10. Allen R.H., Stabler S.P., Savage D.G., Lindenbaum J. Diagnosis of cobalamin deficiency: I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am. J. Hematol. 34:1990;90-98.
11. 12 binding by transcobalamin II increases the risk of neural tube defects. Q. J. Med. 94:2001;159-166.
12. Jacobsen D.W. The transcobalamin II delivery system: an overview. Bhatt H.R., James V.H.T., Besser G.M., Bottazzo G., Keen H. Advances in Thomas Addison's Diseases. vol. 2:1994;224-240 Society of Endocrinology and Thomas Addison Society, Bristol.
13. 12 Proteins. 1998;461-476 Wiley-VCH, Weinheim.
14. Seetharum B., Li N. Transcobalamin II and its cell surface receptor. Vitam. Horm. 59:2000;337-366.
15. Gimsing P., Nexo E. Cobalamin-binding capacity of haptocorrin and transcobalamin: age-correlated reference intervals and values from patients. Clin. Chem. 35:1989;1447-1451.
16. Daiger S.P., Labowe M.L., Parsons M., Wang L., Cavalli-Sforza L.L. Detection of genetic variation with radioactive ligands: III. Genetic polymorphism of transcobalamin II in human plasma. Am. J. Hum. Genet. 30:1978;202-214.
17. Frater-Schroder M., Hitzig W.H., Butler R. Studies on transcobalamin (TC). I. Detection of TC II isoproteins in human serum. Blood. 53:1979;193-203.
18. Frater-Schroder M. Genetic patterns of transcobalamin II and the relationships with congenital defects. Mol. Cell. Biochem. 56:1983;5-31.
19. Hansen M., Frater-Schroder M. Human transcobalamin isopeptides: separation by isoelectric focusing and by polyacrylamide gel electrophoresis. Electrophoresis. 8:1987;221-223.
20. Hansen M., Nexo E. Isoelectric focusing of apo- and holo-transcobalamin present in human blood. Identification of a protein complexing with transcobalamin. Biochim. Biophys. Acta. 992:1989;209-214.
21. Li N., Sood G.K., Seetharam S., Seetharam B. Polymorphism of human transcobalamin II: substitution of proline and/or glutamine residues by arginine. Biochim. Biophys. Acta. 1219:1994;515-520.
22. Namour F., Guy M., Aimone-Gastin I., de Nonancourt M., Mrabet N., Gueant J.E. Isoelectrofocusing phenotype and relative concentration of transcobalamin II isoprotein related to the codon 259 Arg/Pro polymorphism. Biochem. Biophys. Res. Commun. 251:1998;769-774.
23. McCaddon A., Blennow K., Hudson P., Regland B., Hill D. Transcobalamin polymorphism and homocysteine. Blood. 98:2001;3497-3499.
24. Namour F., Olivier J., Abdelmouttaleh I.et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood. 97:2001;1092-1098.
25. 12 status in healthy older adults. Blood. 100:2002;718-720.
26. Rubin L.A., Hawker G.A., Cole D.E.C., Peltekova V., Fielding L., Ridout R. Determination of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J. Bone Miner. Res. 14:1999;633-643.
27. Cole D.E., Vieth R., Trang H.M., Wong B.Y.L., Hendy G.N., Rubin L.A. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol. Genet. Metab. 72:2001;168-174.
28. Rust S., Funke H., Assman G. Mutagenically-separated PCR (MS-PCR): a highly specific one-step procedure for easy mutation detection. Nucleic Acids Res. 21:1993;3623-3629.
29. Weir B.S. Genetic Data Analysis II. 1996;91-138 Sinauer Associates Inc. Sunderland, MA.
30. Lievers K.J.A., Afman L.A., Kluitmans L.A.J.et al. Polymorphism in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin. Chem. 48:2002;1383-1389.
31. Zetterberg H., Regland B., Palmer M., Rymo L., Zafiropoulos A., Arvanitis D.A.et al. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum. Reprod. 17:2002;3033-3036.
32. Zetterberg H., Coppola A., D'Angelo A.D., Palmer M., Rymo L., Blennow K. No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphism and hyperhomocysteinemia in thrombotic disease. Thromb. Res. 108:2003;127-131.
33. Zetterberg H., Nexo E., Regland B.et al. The transcobalamin (TC) codon 259 genetic polymorphism influences holo-tc concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin. Chem. 49:2003;1195-1198.
34. Boushey C.J., Beresford S.A.A., Omenn G.S.et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
35. Yoo J.H., Chung C.S., Kang S.S. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke. 29:1998;2478-2483.
36. Bostorn A.G., Rosenberg I.H., Silbershatz H.et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham study. Ann. Intern. Med. 131:1999;352-355.
37. Bostorn A.G., Silbershatz H., Rosenberg I.H.et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch. Intern. Med. 159:1999;1077-1080.
38. 12) deficiency. J. Am. Geriatr. Soc. 43:1995;1290-1297.
39. Nygard O., Vollset S.E., Refsum H., Brattstrom L., Ueland P.M. Total homocysteine and cardiovascular disease. J. Intern. Med. 246:1999;425-454.
40. Hussein W.I., Green R., Jacobsen D.W.et al. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann. Intern. Med. 131:1999;348-351.
41. Namour F., Gueant J.L. Transcobalamin polymorphism, homocysteine and aging. Blood. 98:2001;3499.
42. Carmel R., Green R., Jacobsen D.W., Rasmussen K., Florea M., Azen C. Serum cobalamin, homocysteine and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am. J. Clin. Nutr. 1999;904-910.